NCT07151235

Brief Summary

This study will examine how breathing wildfire-related air pollution (WRAP) for one hour affects healthy adults. The main question the study will answer if the effect of WRAP exposure on p-tau, a blood marker of cognitive decline. The changes in p-tau concentrations after exposure to WRAP will be compared to the changes in p-tau after exposure to clean air. Participants will:

  • Have 2 study visits - one visit with exposure to clean air and one visit with exposure to simulated wildfire smoke
  • Have blood drawn before and after each exposure
  • Complete cognitive tests and memory tasks before and after each exposure

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

September 18, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2025

Completed
Last Updated

December 2, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

August 25, 2025

Last Update Submit

November 24, 2025

Conditions

Keywords

wildfiresair pollutionultrafine particlescognitive function

Outcome Measures

Primary Outcomes (1)

  • Changes in plasma P-tau 217 concentration from pre-exposure to post-exposure

    Using blood samples collected pre- and post-exposure, the primary outcome will be assessed by measurement of plasma phosphorylated tau at threonine 217 (p-tau217) using an ultrasensitive immunoassay

    Immediately before, immediately after each exposure

Study Arms (2)

Exposure to simulated wildfire smoke, then exposure to clean air

EXPERIMENTAL

At the first study visit the subject undergoes a 1-hour chamber exposure to simulated wildfire smoke (300 ug/m3 Particulate Matter). After a 1-week washout period, the subject undergoes a 1-hour chamber exposure to clean air (0 ug/m3 PM).

Other: Simulated wildfire smoke exposureOther: Clean Air exposure

Exposure to clean air, then exposure to simulated wildfire smoke

EXPERIMENTAL

At the first study visit the subject undergoes a 1-hour chamber exposure to clean air (0 ug/m3 PM). After a 1-week washout period, the subject undergoes a 1-hour chamber exposure to simulated wildfire smoke (300 ug/m3 PM).

Other: Simulated wildfire smoke exposureOther: Clean Air exposure

Interventions

1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)

Exposure to clean air, then exposure to simulated wildfire smokeExposure to simulated wildfire smoke, then exposure to clean air

1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)

Exposure to clean air, then exposure to simulated wildfire smokeExposure to simulated wildfire smoke, then exposure to clean air

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Non smoker
  • Weight at least 110 pounds
  • Between ages 18 and 40 years old

You may not qualify if:

  • Claustrophobia or not comfortable in enclosed spaces.
  • Colorblindness.
  • Inability to hear verbal instructions.
  • Cardiovascular disease which, in the opinion of the investigator, would elevate the participant's risk of adverse effects to WRAP exposure. This includes a history of stroke.
  • Diabetes requiring the use of insulin.
  • Pregnancy (A pregnancy test will be provided to you).
  • Current asthma (an asthma attack within the past five years).
  • History of childhood asthma.
  • Medications which may affect cognition such as beta-blockers and CNS depressants.
  • Respiratory symptoms in the previous 4 weeks (cough, wheezing, shortness of breath, etc.) which, in the opinion of the investigator, would elevate the participant's risk of adverse effects to WRAP exposure.
  • Use of sedating cold/allergy medications in the previous week.
  • Use of marijuana in the previous week.
  • Consumption of alcohol in the previous 24 hours.
  • Kidney or liver disease.
  • Thyroid disease.
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers-EOHSI

Piscataway, New Jersey, 08854, United States

Location

MeSH Terms

Conditions

Pemphigus and fogo selvagem

Study Officials

  • Jose G Cedeno-Laurent, ScD

    Rutgers, The State University of New Jersey: New Brunswick/Piscataway Campus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
outside laboratories processing blood samples
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants will be exposed to two conditions (clean air and wildfire smoke) in random order.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 25, 2025

First Posted

September 3, 2025

Study Start

September 18, 2025

Primary Completion

November 20, 2025

Study Completion

November 20, 2025

Last Updated

December 2, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers.

Locations